V. Poulaki
Boston University(US)VA Boston Healthcare System(US)
Publications by Year
Research Areas
Retinal Diseases and Treatments, Cell death mechanisms and regulation, Ocular Diseases and Behçet’s Syndrome, Retinal and Optic Conditions, Cancer-related Molecular Pathways
Most-Cited Works
- Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.(2001)
- → The Role of Advanced Glycation End Products in Retinal Microvascular Leukostasis(2003)171 cited
- → VEGF164(165)as the Pathological Isoform: Differential Leukocyte and Endothelial Responses through VEGFR1 and VEGFR2(2004)156 cited
- Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.(2001)
- Rapid ocular angiogenic control via naked DNA delivery to cornea.(2001)
- Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.(2000)
- In vivo retinal gene expression in early diabetes.(2001)
- Stimulation of tumor growth by recombinant human insulin-like growth factor-I (IGF-I) is dependent on the dose and the level of IGF-I receptor expression.(1998)
- → Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases(2001)59 cited
- → Fas-Mediated Apoptosis in Ewing's Sarcoma Cell Lines by Metalloproteinase Inhibitors(1999)53 cited